Matthew M. Seavey, PhD, MBA – Founder & President of BioPoint Consulting, LLC He holds a PhD in immunology and has completed postdoctoral fellowships and training in cancer immunotherapy and autoimmunity. He is also published in the field of immunology and holds several patents describing inventions including cancer vaccines and small molecules targeting inflammatory diseases. Holds a decade of drug development experience. Originally trained as an immunologist and an expert in preclinical animal models, Matt has been involved in the development of different drug modalities (biologics, small molecules, cellular therapeutics, vaccines) across multiple therapeutic areas including, GI, immuno-oncology, inflammatory and cardio-metabolic diseases. Matt has held former positions as drug discovery team leader at Cephalon and global pharmacology project leader at Teva Pharmaceuticals. Matt is a co-inventor on several patents and has contributed to the intellectual property base of Advaxis and founding of Oncoceutics. Most recently, he served as program director at United Therapeutics where he was responsible for oversight of clinical oncology activities.